View Cart (0 items)
Cooling of dialysis fluids protects against brain damage

Simple step may help protect against cognitive, psychological, and functional abnormalities in dialysis patients

Records to go public on DaVita whistleblower case

A judge who recently questioned the validity of testimony provided by DaVita employees in a whistleblower case over alleged Medicare fraud has decided to unseal court records in the seven-year-old case

Keryx stock value dives after investors raise concerns about warning on new phosphate binder

The price of Keryx Biopharmaceuticals Inc.’s stock has dropped almost $4 a share since last week over what the company said was a misinterpretation by investors of a label indication to its new phosphate binder

Dialysis groups say CMS' delay of 5-star rating implementation not good enough

CMS' announcement that it would delay the implementation of its five-star rating system for dialysis facilities until January has drawn criticism from renal groups that had hoped CMS would work to re-design the rating system and accept more input from the community

WHAT'S NEW

Rss

Blogs

Misleading patients: CMS blindly charges ahead with 5-Star

Misleading patients: CMS blindly charges ahead with 5-Star

Last week, in spite of overwhelmingly negative response from the renal community, CMS announced it is moving forward with the release of the 5-Star rating system in January.

More
Schreiber talks about moving home therapies forward at DaVita

Schreiber talks about moving home therapies forward at DaVita

Moving more patients into home therapies should be just part of a sequence of options when treating kidney disease long term, says the new head of home modalities at DaVita Kidney Care

More

WHAT'S NEW

Rss

Blogs

Misleading patients: CMS blindly charges ahead with 5-Star

Misleading patients: CMS blindly charges ahead with 5-Star

Last week, in spite of overwhelmingly negative response from the renal community, CMS announced it is moving forward with the release of the 5-Star rating system in January.

More
Schreiber talks about moving home therapies forward at DaVita

Schreiber talks about moving home therapies forward at DaVita

Moving more patients into home therapies should be just part of a sequence of options when treating kidney disease long term, says the new head of home modalities at DaVita Kidney Care

More